BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28179447)

  • 21. Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome).
    Raff H
    Pituitary; 2022 Oct; 25(5):698-700. PubMed ID: 35334030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How early can one diagnose Cushing's disease? An early diagnosis in a case of prepubertal Cushing's disease.
    Hoppmann J; Wagner IV; Junghans G; Wudy SA; Buchfelder M; Hirsch FW; Ritter L; Kiess W; Pfäffle R
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1043-7. PubMed ID: 25367688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and diagnosis of Cushing's syndrome.
    Castro Md; Moreira AC
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1191-8. PubMed ID: 18209856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
    Findling JW; Raff H; Aron DC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer diagnostic techniques and problems in Cushing's disease.
    Findling JW; Raff H
    Endocrinol Metab Clin North Am; 1999 Mar; 28(1):191-210. PubMed ID: 10207691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.
    Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC
    Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone infusion testing in the diagnosis of Cushing's syndrome.
    Tran HA; Petrovsky N
    Endocr J; 2005 Feb; 52(1):103-9. PubMed ID: 15758565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.
    Carroll T; Raff H; Findling JW
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):344-50. PubMed ID: 18446140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
    Kuzu I; Zuhur SS; Demir N; Aktas G; Yener Ozturk F; Altuntas Y
    Endokrynol Pol; 2016; 67(5):487-492. PubMed ID: 26884297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cushing's syndrome: from physiological principles to diagnosis and clinical care.
    Raff H; Carroll T
    J Physiol; 2015 Feb; 593(3):493-506. PubMed ID: 25480800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cushing's disease.
    Bertagna X; Guignat L; Groussin L; Bertherat J
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):607-23. PubMed ID: 19945026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Penezić Z; Zarković M; Vujović S; Drezgić M
    Srp Arh Celok Lek; 2006; 134(11-12):558-66. PubMed ID: 17304774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological correlates of adrenal Cushing's syndrome.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
    Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
    J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
    Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
    J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.